MediPharm Labs
MediPharm Labs has terminated the previously announced sale of its facility in Napanee, Ontario to Kensana Health, which was to be completed through the sale of the company's wholly-owned subsidiary ABcann Medicinals to Kensana Health.
The company has given notice of termination as required under the agreement, as Kensana Health did not meet certain agreed upon terms and conditions within the timelines set out therein. Pursuant to the terms of the agreement, MediPharm Labs will retain certain non-refundable deposits received from Kensana Health.
MediPharm Labs' current commercial agreements and operations at the Napanee Facility are expected to continue without disruption.
